Lipid Nanoparticles Market

Lipid nanoparticles sales will strengthen through 2035, with solid lipid nanoparticles and nanostructured lipid carriers commanding significant share over the assessment period. Therapeutics lead application demand as RNA medicines and oncology pipelines expand. The market is expected to reach USD 1,144.7 million in 2025 and USD 4,244 million by 2035.